Korea Widens Financial Transaction Monitoring With Close Eye On Drug Companies
This article was originally published in PharmAsia News
Executive Summary
South Korea’s version of the U.S. Internal Revenue Service has joined the crackdown on illegal drug rebates by scanning for signs of money laundering or tax evasion by pharmaceutical companies.